Natural products as a resource for new drugs

被引:249
作者
Clark, AM [1 ]
机构
[1] UNIV MISSISSIPPI, SCH PHARM, PHARMACEUT SCI RES INST, NATL CTR DEV NAT PROD, UNIVERSITY, MS 38677 USA
关键词
D O I
10.1023/A:1016091631721
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Natural products have served as a major source of drugs for centuries, and about half of the pharmaceuticals in use today are derived from natural products. The aim of this review is to provide an overview of the continuing central role of natural products in the discovery and development of new pharmaceuticals. In this context, selected examples of important natural product-derived drugs are cited, focusing on some of the most recent introductions to the clinical setting, and a brief overview of some of the important recent developments and remaining challenges in the process of discovering and developing bioactive natural products is provided. Interest in natural products research is strong and can be attributed to several factors, including unmet therapeutic needs, the remarkable diversity of both chemical structures and biological activities of naturally occurring secondary metabolites, the utility of bioactive natural products as biochemical and molecular probes, the development of novel and sensitive techniques to detect biologically active natural products, improved techniques to isolate, purify, and structurally characterize these active constituents, and advances in solving the demand for supply of complex natural products. Opportunities for multidisciplinary research that joins the forces of natural products chemistry, molecular and cellular biology, synthetic and analytical chemistry, biochemistry, and pharmacology to exploit the vast diversity of chemical structures and biological activities of natural products are discussed.
引用
收藏
页码:1133 / 1141
页数:9
相关论文
共 38 条
[1]   MEVINOLIN - A HIGHLY POTENT COMPETITIVE INHIBITOR OF HYDROXYMETHYLGLUTARYL-COENZYME-A REDUCTASE AND A CHOLESTEROL-LOWERING AGENT [J].
ALBERTS, AW ;
CHEN, J ;
KURON, G ;
HUNT, V ;
HUFF, J ;
HOFFMAN, C ;
ROTHROCK, J ;
LOPEZ, M ;
JOSHUA, H ;
HARRIS, E ;
PATCHETT, A ;
MONAGHAN, R ;
CURRIE, S ;
STAPLEY, E ;
ALBERSSCHONBERG, G ;
HENSENS, O ;
HIRSHFIELD, J ;
HOOGSTEEN, K ;
LIESCH, J ;
SPRINGER, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (07) :3957-3961
[2]  
ALLEGRETTO EA, 1993, J BIOL CHEM, V268, P26625
[3]   THE CHEMOTHERAPY OF ONCHOCERCIASIS .10. AN ASSESSMENT OF 4 SINGLE DOSE TREATMENT REGIMES OF MK-933 (IVERMECTIN) IN HUMAN ONCHOCERCIASIS [J].
AWADZI, K ;
DADZIE, KY ;
SHULZKEY, H ;
HADDOCK, DRW ;
GILLES, HM ;
AZIZ, MA .
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 1985, 79 (01) :63-78
[4]   CURARE-LIKE ACTION OF POLYMETHYLENE BIS-QUATERNARY AMMONIUM SALTS [J].
BARLOW, RB ;
ING, HR .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1948, 3 (04) :298-304
[5]  
Baum R, 1996, CHEM ENG NEWS, V74, P28, DOI 10.1021/cen-v074n013.p028
[6]  
Berdy J., 1980, CRC HDB ANTIBIOTIC C
[7]  
BRADLEY SG, 1995, PRINCIPLES PHARM BAS, P1437
[8]   CRYSTAL AND MOLECULAR-STRUCTURE OF COMPACTIN, A NEW ANTIFUNGAL METABOLITE FROM PENICILLIUM-BREVICOMPACTUM [J].
BROWN, AG ;
SMALE, TC ;
KING, TJ ;
HASENKAMP, R ;
THOMPSON, RH .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1976, (11) :1165-1173
[9]  
Buss AD, 1995, BURGERS MED CHEM DRU, P983, DOI [10.1002/0471266949.bmc018, DOI 10.1002/0471266949.BMC018]
[10]  
CHENG XM, 1994, ANNU REP MED CHEM, V29, P331